Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,129 | 16,185 | 30,746 | 30,244 | 75,618 |
| Marketable Securities | 36,708 | 51,329 | 17,209 | 19,621 | 18,858 |
| Receivables | 570 | 645 | 730 | 892 | 2,493 |
| Other current assets | 0 | 339 | 0 | 0 | 0 |
| TOTAL | $64,538 | $79,560 | $58,210 | $60,415 | $107,076 |
| Non-Current Assets | |||||
| PPE Net | 7,915 | 9,013 | 10,323 | 11,123 | 12,278 |
| Intangibles | 18,727 | 18,863 | 19,077 | 19,168 | 19,303 |
| Other Non-Current Assets | 10,641 | 13,550 | 13,825 | 12,610 | 16,783 |
| TOTAL | $37,283 | $41,426 | $43,225 | $42,901 | $48,364 |
| Total Assets | $101,821 | $120,986 | $101,435 | $103,316 | $155,440 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,816 | 2,701 | 2,692 | 8,461 | 9,780 |
| Accounts payable and accrued liabilities | 639 | 6,087 | 2,480 | 2,782 | 3,370 |
| Accrued Expenses | 28,567 | 23,113 | 15,745 | 18,592 | 17,558 |
| Other current liabilities | 2,270 | N/A | N/A | N/A | N/A |
| TOTAL | $34,372 | $31,981 | $20,997 | $29,915 | $30,788 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,667 | 5,242 | 5,993 | 6,556 | 7,326 |
| Deferred Revenues | 80 | 80 | 80 | 80 | 80 |
| Other Non-Current Liabilities | 163,908 | 168,410 | 176,100 | 165,248 | 223,865 |
| TOTAL | $169,053 | $174,150 | $182,611 | $172,342 | $231,749 |
| Total Liabilities | $203,425 | $206,131 | $203,608 | $202,257 | $262,537 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13 | 12 | 9 | 9 | 8 |
| Common Shares | 860,691 | 843,600 | 798,419 | 780,926 | 721,544 |
| Retained earnings | -961,108 | -927,690 | -899,492 | -878,492 | -825,289 |
| Other shareholders' equity | -1,187 | -1,055 | -1,100 | -1,375 | -3,352 |
| TOTAL | $-101,604 | $-85,145 | $-102,173 | $-98,941 | $-107,097 |
| Total Liabilities And Equity | $101,821 | $120,986 | $101,435 | $103,316 | $155,440 |